Physician
Urology
Dr. Gerald W. Chodak, MD
|
|
Give Review
Dr. Gerald W. Chodak works in the field of Urology. He studied medicine at University at Buffalo, School of Medicine and Biomedical Sciences. Dr. Gerald W. Chodak is a published physician as well. He has 97 publications published. The latest was: Comparing treatments for localized prostate cancer--persisting uncertainty.
Publications
- Lower baseline prostate-specific antigen is associated with a greater overall survival benefit from sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treat...
- A decision aid for teaching limitations of prostate cancer screening.
- Is the increase in orchiectomy for prostate cancer patients appropriate?
- Do "rapid" PSA assays reduce anxiety and stress of prostate cancer patients undergoing regular review? A prospective evaluation.
- Combined androgen blockade in advanced prostate cancer: looking back to move forward.
- Assessment of American urologists' approach to hormonal management of prostate cancer.
- The bicalutamide 150 mg early prostate cancer program: findings of the North American trial at 7.7-year median followup.
- Are bone scans necessary in men with low prostate specific antigen levels following localized therapy?
- Watchful waiting for prostate cancer: a review article.
- Prostate cancer: epidemiology, screening, and biomarkers.
- [Usefulness and positioning of MAB therapy for prostate cancer].
- Re: Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis.
- Maximum androgen blockade: a clinical update.
- Natural history of early localized prostate cancer.
- Combination hormonal therapy: a reassessment within advanced prostate cancer.
- Should the therapeutic approach to prostate cancer with seminal vesicle invasion be reviewed: improving functional results without diminishing oncological outcome?
- The role of 111indium-capromab pendetide imaging for assessing biochemical failure after radical prostatectomy.
- An analysis of risk factors for biochemical progression in patients with seminal vesicle invasion: validation of Kattan''s nomogram in a pathological subgroup.
- Is the efficacy of hormonal therapy affected by lymph node status? data from the bicalutamide (Casodex) Early Prostate Cancer program.
- An evaluation of intermediate-dose ketoconazole in hormone refractory prostate cancer.
- Current trends in the management of radical retropubic prostatectomy: is short-stay RRP feasible in the United Kingdom?
- Can leakage at the vesico-urethral anastomosis be predicted after radical retropubic prostatectomy?
- A critical review of maximal androgen blockade for advanced prostate cancer.
- Editorial panel on informed consent for PSA screening.
- Prostatectomy - a radical approach.
- Critical review of complementary therapies for prostate cancer.
- Educating African-American men about prostate cancer: impact on awareness and knowledge.
- Informed consent for prostate-specific antigen screening.
- Attitudes and use of complementary medicine in men with prostate cancer.
- Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the ea...
- Critical evaluation of hormonal therapy for carcinoma of the prostate.
- Intention to be tested for prostate cancer risk among African-American men.
- Using outcome data and patient satisfaction surveys to develop policies regarding minimum length of hospitalization after radical prostatectomy.
- Adherence by African American men to prostate cancer education and early detection.
- Endocrine effects, efficacy and tolerability of a 10.8-mg depot formulation of goserelin acetate administered every 13 weeks to patients with advanced prostate cancer.
- Comparing treatments for localized prostate cancer--persisting uncertainty.
- Comparison of goserelin and leuprolide in combined androgen blockade therapy.
- Overnight hospitalization after radical prostatectomy: the impact of two clinical pathways on patient satisfaction, length of hospitalization, and morbidity.
- Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms.
- Evaluation of changes in prostate specific antigen in clinically localized prostate cancer managed without initial therapy.
- Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument.
- Bicalutamide-associated fulminant hepatic failure.
- Improved detection of recurrent bladder cancer using the Bard BTA stat Test.
- Carcinoma of the prostate.
- Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis.
- Defining the role of surveillance in the management of localized prostate cancer.
- Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract.
- Results of radical prostatectomy in men with clinically localized prostate cancer.
- Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment.
- Treatment of prostate cancer using external beam radiotherapy after laparoscopic pelvic lymph node dissection.
- Re: Long-term survival and mortality in prostate cancer treated with noncurative intent.
- Additional therapy after prostatectomy: implications for patient counseling.
- Immunohistochemical evaluation of proliferating cell nuclear antigen, prostate-specific antigen and alpha 1-antichymotrypsin in human prostate cancer.
- A controlled trial of bicalutamide versus castration in patients with advanced prostate cancer.
- Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II multicenter trial.
- Same day surgery for radical retropubic prostatectomy: is it an attainable goal?
- Association of nm23 protein levels in human prostates with proliferating cell nuclear antigen expression at autopsy.
- Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma.
- What to expect from prostate cancer.
- Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II noncomparative multicenter trial evaluating safety, efficacy and long-term endocrine effects ...
- Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy.
- Prostate cancer staging after radiation utilizing laparoscopic pelvic lymphadenectomy.
- Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer.
- Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study Group.
- In vitro anti-invasive effects of N-(4-hydroxyphenyl)-retinamide on human prostatic adenocarcinoma.
- Combined laparoscopic and transurethral neodymium: yttrium-aluminum-garnet laser treatment of invasive bladder cancer.
- Conservative management of clinically-localized prostate cancer.
- Effect of age, educational status, ethnicity and geographic location on prostate symptom scores.
- The role of watchful waiting in the management of localized prostate cancer.
- Cryosurgery for stage T3 prostate cancer.
- The role of conservative management in localized prostate cancer.
- Screening for prostate cancer. The debate continues.
- N-(4-hydroxyphenyl) retinamide induces cell cycle specific growth inhibition in PC3 cells.
- Laparoscopic bilateral nephrectomy for renin-mediated hypertension.
- Receptivity of African-American men to prostate cancer screening.
- High levels of nm23 expression are related to cell proliferation in human prostate cancer.
- Laparoscopic pelvic lymph node dissection: a review of 103 consecutive cases.
- Results of conservative management of clinically localized prostate cancer.
- Treatment of early stage prostate cancer: conservative management--delayed therapy.
- Disease-specific survival following routine prostate cancer screening by digital rectal examination: corrected patient classification.
- Buschke-Lowenstein tumor: therapeutic options including systemic chemotherapy.
- The application of laparoscopy to retroperitoneal surgery in urology.
- Prognostic factors in stage D2 prostate cancer treated with a pure nonsteroidal antiandrogen.
- Cryosurgery of the prostate revisited.
- Questioning the value of screening for prostate cancer in asymptomatic men.
- Blindness secondary to prostate cancer.
- Screening for prostate cancer in 1993: is it appropriate, or not?
- The role of laparoscopic lymphadenectomy in staging and treatment of urological tumours.
- Methotrexate, vinblastine, doxorubicin and cisplatin followed by radiotherapy or surgery for muscle invasive bladder cancer: the University of Chicago experience.
- Complications of laparoscopic pelvic lymph node dissection.
- Screening and early detection of prostate cancer.
- Disease-specific survival following routine prostate cancer screening by digital rectal examination.
- Workshop summary: screening policies and procedures.
- Value of prostate cancer screening.
- Early diagnosis of prostate cancer.
- Current and future roles of laparoscopic surgery in urology.
Schools
State University of New York At Buffalo
Brigham and Women39s Hospital
Kaleida Health Sys Buffalo Gen
UCLA Med Center
University Of Chicago Hosps
Doctors Specialties
- Urology
Accepted Insurances
Education
-
University of Chicago -
Brigham and Women's Hospital -
UCLA Medical Center -
University at Buffalo, School of Medicine and Biomedical Sciences
Helpful Reviews
Similar Doctors
|
|
Dr. Courtney M. Hollowell, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William J. Catalona, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Leon Lome, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael S. Gomez, MD |
|
Dr. Paul Yonover, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Traci P. Beck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashay V. Kparker, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ronald B. Neal, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Roger A. Villalba, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elodi J. Dielubanza, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James T. Kearns, MD |
|
|
Dr. Hannah J. Alphs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam B. Murphy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kyle A. Richards, MD |
|
|
Dr. Joseph J. Pariser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rena D. Malik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vignesh T. Packiam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Brian J. Jordan |
|
|
Christopher D. Morrison |